With all due respect, what you are saying simply isn't true. The 180 day revue process is no guarantee of approval. Just as many applications are ultimately rejected under Avita's PDA path as are applications processed under the normal PDA revue path.
I personally believe they will get approval, but it's never 100%.
- Forums
- ASX - By Stock
- Don't consider selling before profitability
With all due respect, what you are saying simply isn't true. The...
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.65 |
Change
-0.020(0.75%) |
Mkt cap ! $159.5M |
Open | High | Low | Value | Volume |
$2.68 | $2.70 | $2.63 | $496.8K | 185.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8481 | $2.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.68 | 13000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8481 | 2.650 |
1 | 5092 | 2.640 |
4 | 10466 | 2.630 |
1 | 1000 | 2.620 |
8 | 9040 | 2.610 |
Price($) | Vol. | No. |
---|---|---|
2.680 | 13000 | 2 |
2.690 | 86 | 1 |
2.700 | 8409 | 2 |
2.720 | 1000 | 1 |
2.730 | 950 | 2 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$2.66 |
  |
Change
-0.020 ( 0.15 %) |
|||
Open | High | Low | Volume | ||
$2.69 | $2.70 | $2.64 | 11993 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
AVH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online